Get startedLog in
    Picture of Syngene International logo

    SYNGENE — Syngene International Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Syngene International, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3,9584,6445,1004,9623,167
    Depreciation
    Non-Cash Items1,6061,4765002,0201,568
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-2,855-1,550562368-112
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities5,8068,23510,42111,6769,152
    Capital Expenditures-4,755-5,183-5,108-7,701-3,682
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1,360-1,381152254-4,922
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-6,115-6,564-4,956-7,447-8,604
    Financing Cash Flow Items-175-345-289-137-106
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-313-3,425-5,515-1,417-2,150
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-615-1,723-392,815-1,385